Silvia Tardivo

Silvia Tardivo

Auto-generated profile, based on publicly available information

Silvia Tardivo

Neurogenetics Unit, IRCCS Santa Lucia Foundation, Rome 00143, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RMRoberta De Mori
Roberta De Mori
MRMarta Romani
Marta Romani
SDStefano D’aRrigo
Stefano D’aRrigo
MZMaha S. Zaki
Maha S. Zaki
ELElisa Lorefice
Elisa Lorefice
EVEnza Maria Valente
Enza Maria Valente

1 August 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FSFrancesco Spallotta
Francesco Spallotta
STSilvia Tardivo
Silvia Tardivo
SNSimona Nanni
Simona Nanni
JRJessica D Rosati
Jessica D Rosati
SSStefania Straino
Stefania Straino
CCClaudia. Colussi
Claudia. Colussi
Histone deacetylase inhibitors (DIs) are promising drugs for the treatment of several pathologies including ischemic and failing heart where they demonstrated efficacy. However, adverse side effects and cardiotoxicity have also been reported. Remarkably, no information is available about the effect of DIs during tissue regeneration following acute peripheral ischemia. In this study, mice made ischemic by femoral artery excision were injected with the DIs MS275 and MC1568, selective for class I and IIa histone deacetylases (HDACs), respectively. In untreated mice, soon after damage, class IIa HDAC phosphorylation and nuclear export occurred, paralleled by dystrophin and neuronal nitric-oxide synthase (nNOS) down-regulation and decreased protein phosphatase 2A activity. Between 14 and 21 days after ischemia, dystrophin and nNOS levels recovered, and class IIa HDACs relocalized to the nucleus. In this condition, the MC1568 compound increased the number of newly formed muscle fibers but delayed their terminal differentiation, whereas MS275 abolished the early onset of the regeneration process determining atrophy and fibrosis. The selective DIs had differential effects on the vascular compartment: MC1568 increased arteriogenesis whereas MS275 inhibited it. Capillarogenesis did not change. Chromatin immunoprecipitations revealed that class IIa HDAC complexes bind promoters of proliferation-associated genes and of class I HDAC1 and 2, highlighting a hierarchical control between class II and I HDACs during tissue regeneration. Our findings indicate that class-selective DIs interfere with normal mouse ischemic hindlimb regeneration and suggest that their use could be limited by alteration of the regeneration process in peripheral ischemic tissues.

8 November 2021 in Human Mutation
Verified
Journal Article
Closed access
PDF file
SNSara Nuovo
Sara Nuovo
VBValentina Baglioni
Valentina Baglioni
RMRoberta De Mori
Roberta De Mori
STSilvia Tardivo
Silvia Tardivo
CCCaterina Caputi
Caterina Caputi
VLVincenzo Leuzzi
Vincenzo Leuzzi

1 March 2018 in Stem Cell Research
Verified
Journal Article
Open access
JRJessica D Rosati
Jessica D Rosati
FAFilomena Altieri
Filomena Altieri
STSilvia Tardivo
Silvia Tardivo
ETElisa Maria Turco
Elisa Maria Turco
MGMarina Goldoni
Marina Goldoni
AVAngelo Luigi Vescovi
Angelo Luigi Vescovi
Joubert Syndrome (JS) is a rare autosomal recessive or X-linked condition characterized by a peculiar cerebellar malformation, known as the molar tooth sign (MTS), associated with other neurological phenotypes and multiorgan involvement. JS is a ciliopathy, a spectrum of disorders whose causative genes encode proteins involved in the primary cilium apparatus. In order to elucidate ciliopathy-associated molecular mechanisms, human induced pluripotent stem cells (hiPSCs) were derived from a patient affected by JS carrying a homozygous missense mutation in the AHI1 gene (p.H896R) that encodes a protein named Jouberin.